Gonadoblastoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:206484OMIM:424500D39.1
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Gonadoblastoma is a rare gonadal neoplasm that arises almost exclusively in individuals with disorders of sex development (DSD) who carry Y chromosome material in their karyotype, most commonly those with 46,XY complete gonadal dysgenesis (Swyer syndrome), 45,X/46,XY mixed gonadal dysgenesis, or other forms of gonadal dysgenesis. The tumor is composed of a mixture of germ cells and sex cord-stromal cells resembling immature Sertoli and granulosa cells, typically arising in dysgenetic (streak) gonads. Gonadoblastoma itself is considered a benign or in situ neoplasm, but it carries significant clinical importance because approximately 50–60% of cases can progress to invasive malignant germ cell tumors, most commonly dysgerminoma (seminoma equivalent), and less frequently to other malignant germ cell tumors such as yolk sac tumor, embryonal carcinoma, or choriocarcinoma. Clinically, gonadoblastoma may be discovered incidentally during evaluation for primary amenorrhea, ambiguous genitalia, or delayed puberty in phenotypic females or undervirilized males. Some patients may present with signs of virilization due to testosterone production by the tumor. The tumor can be unilateral or bilateral, with bilateral involvement occurring in approximately 40% of cases. A susceptibility locus on the Y chromosome, termed the gonadoblastoma locus on the Y chromosome (GBY), has been identified, with the TSPY1 gene being a strong candidate for the critical gene involved in tumor development. The primary treatment for gonadoblastoma is prophylactic gonadectomy, which is recommended for individuals with gonadal dysgenesis who carry Y chromosome material, given the high risk of malignant transformation. When gonadoblastoma is identified, surgical removal of both gonads is typically advised, as bilateral disease is common. Following gonadectomy, hormone replacement therapy is necessary to support pubertal development and long-term bone and cardiovascular health. The prognosis for gonadoblastoma itself is excellent after complete surgical removal, though outcomes depend on whether malignant transformation has occurred prior to diagnosis. Regular surveillance and early intervention are key to preventing progression to invasive germ cell malignancies.

Clinical phenotype terms— hover any for plain English:

Abnormality of the ovaryHP:0000137Ovarian gonadoblastomaHP:0000149Female external genitalia in individual with 46,XY karyotypeHP:0008730Gonadal dysgenesis with female appearance, maleHP:0008723Gonadal calcificationHP:0008703Increased serum testosterone levelHP:0030088DysgerminomaHP:0100621
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Gonadoblastoma.

View clinical trials →

No actively recruiting trials found for Gonadoblastoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Gonadoblastoma community →

Specialists

15 foundView all specialists →
GC
Gang Chen
TOWSON, MD
Specialist
1 Gonadoblastoma publication
HL
Hai Li
Specialist
1 Gonadoblastoma publication
WC
Wen Chen
Specialist
1 Gonadoblastoma publication
WS
Wei Shen
Specialist
1 Gonadoblastoma publication
MB
Mei-Ling Bao
Specialist
1 Gonadoblastoma publication
XL
Xiao Li
Specialist
1 Gonadoblastoma publication
HL
Hong-Xia Li
Specialist
1 Gonadoblastoma publication
YL
Ya Li
Specialist
1 Gonadoblastoma publication
ER
Ewa Rudnicka
Specialist
1 Gonadoblastoma publication
AJ
Aleksandra Jaroń
Specialist
1 Gonadoblastoma publication
JK
Jagoda Kruszewska
Specialist
1 Gonadoblastoma publication
RS
Roman Smolarczyk
Specialist
1 Gonadoblastoma publication
KJ
Krystian Jażdżewski
Specialist
1 Gonadoblastoma publication
PD
Paweł Derlatka
Specialist
1 Gonadoblastoma publication
AK
Anna Małgorzata Kucharska
Specialist
1 Gonadoblastoma publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Gonadoblastoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open GonadoblastomaForum →

No community posts yet. Be the first to share your experience with Gonadoblastoma.

Start the conversation →

Latest news about Gonadoblastoma

No recent news articles for Gonadoblastoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Gonadoblastoma

What is Gonadoblastoma?

Gonadoblastoma is a rare gonadal neoplasm that arises almost exclusively in individuals with disorders of sex development (DSD) who carry Y chromosome material in their karyotype, most commonly those with 46,XY complete gonadal dysgenesis (Swyer syndrome), 45,X/46,XY mixed gonadal dysgenesis, or other forms of gonadal dysgenesis. The tumor is composed of a mixture of germ cells and sex cord-stromal cells resembling immature Sertoli and granulosa cells, typically arising in dysgenetic (streak) gonads. Gonadoblastoma itself is considered a benign or in situ neoplasm, but it carries significant c

Which specialists treat Gonadoblastoma?

15 specialists and care centers treating Gonadoblastoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.